ATIQUE A MIRZA

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease HARTFORD, CT NPI 1497701072

General Payments — all program years on this page

$23,765.88

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $18,628.36 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $18,332.179
Abbott Laboratories $166.801
E.R. Squibb & Sons, L.L.C. $75.312
Actelion Pharmaceuticals US, Inc. $32.461
PFIZER INC. $21.621

By program year

Program yearAmountRecords
2018 $23.852
2019 $23.791
2021 $34.092
2022 $336.513
2023 $4,719.285
2024 $18,628.3614

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078874302 Actelion Pharmaceuticals US, Inc. $32.46 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096781124 Novo Nordisk Inc $5,037.50 10/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1096850154 Novo Nordisk Inc $90.50 05/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096889380 Novo Nordisk Inc $296.12 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096927510 Novo Nordisk Inc $11,491.75 05/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1096933127 Novo Nordisk Inc $329.50 07/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1096947869 Novo Nordisk Inc $125.01 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096953214 Novo Nordisk Inc $149.21 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097230869 Novo Nordisk Inc $196.24 05/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097448844 Novo Nordisk Inc $616.34 05/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1101402245 E.R. Squibb & Sons, L.L.C. $35.67 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101402305 E.R. Squibb & Sons, L.L.C. $39.64 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125095107 Abbott Laboratories $166.80 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132049576 PFIZER INC. $21.62 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.